The group, which held its first meeting on 2 July, chaired by Lord Filkin CBE, aims to identify “the most effective ways to increase healthspan and democratise access to the ‘longevity dividend’ for citizens”.
It plans to introduce a national strategy for healthy longevity, to “turn the ‘problem’ of ageing into one of the most promising opportunities of the 21st century – and secure Britain’s place as a global leader in longevity underpinned by ethical AI”.
Professor Santin’s colleagues on the board include experts from around the UK including Professor Sarah Harper from Oxford University, Professor Roy Sandbach OBE from Newcastle University and Dr Richard Siow from King’s College.
Professor Santin is with a focus ranging from bone and cartilage regeneration, cardiovascular devices, control of angiogenesis in cartilage regeneration and ischaemia and neurodegenerative diseases.
He said: “I am honoured to have been appointed to this very important board. I believe this reflects on the quality of research by everyone involved in this field here at the 91¶¶Òõ.”